Evidence map›Paper›PMID 34616298›Full record

ArticleFrontiers in pharmacology2021

Modulation of the Gut Microbiota by

Jaemoo Chun, So Min Lee, You Mee Ahn, Min-Gyung Baek, Hana Yi, Sarah Shin, Jeeyoun Jung

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. ButyrylatedActa pharmaceutica Sinica. B · 2025
    Article
  5. The therapeutic potential ofFrontiers in pharmacology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Frontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jaemoo ChunKM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.
So Min LeeKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.
You Mee AhnKM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.
Min-Gyung BaekInterdisciplinary Program in Precision Public Health, Korea University, Seoul, South Korea.
Hana YiSchool of Biosystems and Biomedical Sciences, Korea University, Seoul, South Korea.
Sarah ShinKM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.
Jeeyoun JungKM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.
Korea Institute of Oriental Medicine · KRKorea University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by complex immune dysregulation and closely related to the gut microbiome. The present study investigated the microbiome-mediated effect of

Indexed as

atopic dermatitisgut microbiomeimmune responseshort-chain fatty acidsSihocheonggan-Tang

Identifiers

PMID34616298
PMCPMC8489559
OpenAlexW3200345777

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.